← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 256 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing256+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services78−3.2 pts t -0.5−2.1 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515570425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

XBIT
XBiotech Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +31.0%/yr vs model +15.0% · above model
XBPEW
XBP Global Holdings, Inc.
Below Treasuries
Technology Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +12.0% · below model
XCH
XCHG Ltd
Below Treasuries
Technology
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +93.8%/yr vs model +2.0% · above model
XCUR
EXICURE, INC.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +28.7%/yr vs model +15.0% · above model
XENE
Xenon Pharmaceuticals Inc.
Below Treasuries
Healthcare Risk 41 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +111.3%/yr vs model +2.0% · above model
XFOR
X4 Pharmaceuticals, Inc
Below Treasuries
Healthcare Risk 48 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +38.9%/yr vs model +15.0% · above model
XHG
XChange TEC.INC
Below Treasuries
Financial Services Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +137.9%/yr vs model +2.0% · above model
XHLD
TEN Holdings, Inc.
Below Treasuries
Technology Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +64.2%/yr vs model +2.0% · above model
XMAX
XMax Inc.
Below Treasuries
Consumer Cyclical Risk 38 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +19.4%/yr vs model +7.4% · above model
XNCR
Xencor Inc
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +65.5%/yr vs model +2.0% · above model
XNET
Xunlei Ltd
Below Treasuries
Technology Risk 33 · Moderate
Yield1.5%
Growth used15.0%
10-yr IRR-0.1%
Grower · 5 yrs positive P/IV —
Market implies +34.3%/yr vs model +17.6% · above model
XOMA
XOMA Royalty Corp
Below Treasuries
Healthcare Risk 54 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +69.6%/yr vs model +2.0% · above model
XOMAO
XOMA Royalty Corp
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +72.6%/yr vs model +2.0% · above model
XOMAP
XOMA Royalty Corp
Below Treasuries
Healthcare Risk 53 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +37.2%/yr vs model +2.0% · above model
XOS
Xos, Inc.
Below Treasuries
Consumer Cyclical Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +49.3%/yr vs model +8.0% · above model
XPO
XPO, Inc.
Below Treasuries
Industrials Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +32.3%/yr vs model +4.0% · above model
XRN
Chiron Real Estate Inc.
Below Treasuries
Financial Services Risk 58 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
XRXDW
Xerox Holdings Corp
Below Treasuries
Technology Risk 54 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +7.6% · below model
XWEL
XWELL, Inc.
Below Treasuries
Consumer Cyclical Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -11.0%/yr vs model +2.0% · below model
XXII
22nd Century Group, Inc.
Below Treasuries
Consumer Defensive Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -30.0%/yr vs model +2.0% · below model
YAAS
Youxin Technology Ltd
Below Treasuries
Technology Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +77.1%/yr vs model +2.0% · above model
YDES
YD Bio Ltd
Below Treasuries
Healthcare Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +43.8%/yr vs model +30.6% · above model
YDKG
Yueda Digital Holding
Below Treasuries
Technology Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -50.0%/yr vs model +25.0% · below model
YJ
Yunji Inc.
Below Treasuries
Consumer Cyclical Risk 26 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +71.1%/yr vs model +2.0% · above model
YMM
Full Truck Alliance Co. Ltd.
Below Treasuries
Technology Risk 34 · Moderate
Yield0.3%
Growth used15.0%
10-yr IRR-17.6%
Grower · 3 yrs positive P/IV —
Market implies +49.9%/yr vs model +21.1% · above model
YMT
Yimutian Inc.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +54.0%/yr vs model +15.0% · above model
YOU
Clear Secure, Inc.
Below Treasuries
Technology
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
YQ
17 Education & Technology Group Inc.
Below Treasuries
Consumer Defensive Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +62.1%/yr vs model +2.0% · above model
YRD
Yiren Digital Ltd.
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -36.7%/yr vs model +3.9% · below model
YSG
Yatsen Holding Ltd
Below Treasuries
Consumer Defensive Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +38.1%/yr vs model +2.0% · above model
YYAI
AIRWA INC.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -4.7%/yr vs model +15.0% · below model
ZBIO
Zenas BioPharma, Inc.
Below Treasuries
Healthcare Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +92.3%/yr vs model +2.0% · above model
ZEPP
Zepp Health Corp
Below Treasuries
Technology Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +28.3%/yr vs model +2.0% · above model
ZETA
Zeta Global Holdings Corp.
Below Treasuries
Technology Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +81.3%/yr vs model +24.5% · above model
ZJYL
Jin Medical International Ltd.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +54.5%/yr vs model +2.0% · above model
ZKIN
ZK International Group Co., Ltd.
Below Treasuries
Industrials Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +69.8%/yr vs model +2.0% · above model
ZLAB
Zai Lab Ltd
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +37.3%/yr vs model +33.5% · above model
ZNTL
Zentalis Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +22.0%/yr vs model +15.0% · above model
ZONE
CleanCore Solutions, Inc.
Below Treasuries
Consumer Defensive Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +47.3%/yr vs model +29.2% · above model
ZSQR
Z Squared Inc.
Below Treasuries
Financial Services Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +15.3%/yr vs model +50.0% · below model
ZUMZ
Zumiez Inc
Below Treasuries
Consumer Cyclical Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +21.1%/yr vs model +2.3% · above model